HRT linked to lower dementia risk when started in midlife
A large-scale study suggests that women who begin hormone replacement therapy (HRT) during midlife may have a lower risk of developing dementia. The research indicates a specific 'window of opportunity' for treatment to be most effective.
Why it matters
This provides significant insight into preventative health strategies for women's cognitive aging.
Disclaimer: By joining, you agree to our Privacy Policy & Terms of Use
Are Media Pty Limited collects your personal information through this site to process registrations, send out newsletters, communicate offers, discounts, competitions, or surveys, and to provide you with targeted advertising based on your online activities. Our Privacy Policy contains information on how you can access or correct your personal information, which entities we may disclose your personal information to (including overseas recipients), how to opt out of targeted advertising, and how to lodge a complaint.
Many women take hormone replacement therapy (HRT) to ease hot flushes , night sweats and other menopause symptoms . But could it also protect your brain years down the track?
New research published in the journal Alzheimer's & Dementia suggests taking HRT in midlife could help protect against dementia .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in